Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1897-4287
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report ; volume:19 ; number:1 ; day:20 ; month:10 ; year:2021 ; pages:1-7 ; date:12.2021
Hereditary cancer in clinical practice ; 19, Heft 1 (20.10.2021), 1-7, 12.2021
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13053-021-00202-0
- URN
-
urn:nbn:de:101:1-2022011318534775036535
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Puzik, Alexander
- Uhl, Markus
- Ruf, Juri
- Schumacher, Tilmann
- Kontny, Udo
- SpringerLink (Online service)
Other Objects (12)
Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report
Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report
Optimierte diagnostische Genauigkeit der F18-FDG-PET zur prätherapeutischen Dignitätsbeurteilung thorakaler Lymphknoten beim nicht-kleinzelligen Lungenkarzinom (NSCLC) : Einfluss einer Dual Time Point-Diagnostik und eines visuellen Befundungsscores
Einsatz Lu-177-basierter Radioligandentherapien bei fortgeschrittener PCa- und NET-Erkrankung: Bestimmung der Nierendosis und deren Einflussfaktoren
Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor
Development of discordant hypermetabolic prostate cancer lesions in the course of [177Lu]PSMA radioligand therapy and their possible influence on patient outcome
[68Ga]Ga-RM2 PET/CT reveals small distant metastases not detected by conventional imaging in primary estrogen receptor-positive breast cancer
[68Ga]Ga-RM2 PET/CT reveals small distant metastases not detected by conventional imaging in primary estrogen receptor-positive breast cancer
Influence of rigid coregistration of PET and CT data on metabolic volumetry: a user’s perspective
Early PSA change after [177Lu]PSMA-617 radioligand therapy as a predicator of biochemical response and overall survival
Bone marrow impairment during early [177Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy
Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report
Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report
Optimierte diagnostische Genauigkeit der F18-FDG-PET zur prätherapeutischen Dignitätsbeurteilung thorakaler Lymphknoten beim nicht-kleinzelligen Lungenkarzinom (NSCLC) : Einfluss einer Dual Time Point-Diagnostik und eines visuellen Befundungsscores
Einsatz Lu-177-basierter Radioligandentherapien bei fortgeschrittener PCa- und NET-Erkrankung: Bestimmung der Nierendosis und deren Einflussfaktoren
Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor
Development of discordant hypermetabolic prostate cancer lesions in the course of [177Lu]PSMA radioligand therapy and their possible influence on patient outcome
[68Ga]Ga-RM2 PET/CT reveals small distant metastases not detected by conventional imaging in primary estrogen receptor-positive breast cancer
[68Ga]Ga-RM2 PET/CT reveals small distant metastases not detected by conventional imaging in primary estrogen receptor-positive breast cancer
Influence of rigid coregistration of PET and CT data on metabolic volumetry: a user’s perspective
Early PSA change after [177Lu]PSMA-617 radioligand therapy as a predicator of biochemical response and overall survival
Bone marrow impairment during early [177Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy
Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report
Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report
Optimierte diagnostische Genauigkeit der F18-FDG-PET zur prätherapeutischen Dignitätsbeurteilung thorakaler Lymphknoten beim nicht-kleinzelligen Lungenkarzinom (NSCLC) : Einfluss einer Dual Time Point-Diagnostik und eines visuellen Befundungsscores
Einsatz Lu-177-basierter Radioligandentherapien bei fortgeschrittener PCa- und NET-Erkrankung: Bestimmung der Nierendosis und deren Einflussfaktoren
Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor
Development of discordant hypermetabolic prostate cancer lesions in the course of [177Lu]PSMA radioligand therapy and their possible influence on patient outcome
[68Ga]Ga-RM2 PET/CT reveals small distant metastases not detected by conventional imaging in primary estrogen receptor-positive breast cancer
[68Ga]Ga-RM2 PET/CT reveals small distant metastases not detected by conventional imaging in primary estrogen receptor-positive breast cancer
Influence of rigid coregistration of PET and CT data on metabolic volumetry: a user’s perspective
Early PSA change after [177Lu]PSMA-617 radioligand therapy as a predicator of biochemical response and overall survival
Bone marrow impairment during early [177Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?